Table 2 Putative protective probiotic strains selected. The selection aims to mimic an immune-enhancing and infection-protective probiotic community in the infant gut. These strains were subjected to subsequent network metabolic network analysis. The “Exogenous metabolite #” column shows the number of exogenous compounds required by each bacterium
Putative probiotic | Exogenous metabolite # |
|---|---|
Bifidobacterium adolescentis ATCC 15703 | 251 |
Bifidobacterium angulatum DSM 20098 | 268 |
Bifidobacterium animalis subsp. lactis BB 12 | 248 |
Bifidobacterium bifidum BGN4 | 255 |
Bifidobacterium breve UCC2003 NCIMB8807 | 258 |
Bifidobacterium catenulatum DSM 16992 | 274 |
Bifidobacterium longum subsp. infantis ATCC 15697 | 295 |
Bifidobacterium longum subsp. longum CCUG 52486 | 289 |
Bifidobacterium pseudocatenulatum DSM 20438 | 283 |
Lactobacillus acidophilus NCFM | 220 |
Lactobacillus casei subsp. casei BL23 | 313 |
Lactobacillus fermentum IFO 3956 | 265 |
Lactobacillus paracasei subsp. paracasei ATCC 25302 | 305 |
Lactobacillus plantarum WCFS1 | 308 |
Lactobacillus reuteri SD2112 ATCC 55730 | 261 |
Lactobacillus rhamnosus GG ATCC 53103 | 276 |
Akkermansia muciniphila ATCC BAA 835 | 208 |
Faecalibacterium prausnitzii M21 2 | 275 |